Beyond IgE—When Do IgE-Crosslinking and Effector Cell Activation Lead to Clinical Anaphylaxis?

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.00871
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA


Related search